3-aryl-substituted quinazolones, and uses thereof

Details for Australian Patent Application No. 2006330883 (hide)

Owner Prolexys Pharmaceuticals, Inc.

Inventors Venkat, Raj Gopal; Selliah, Robert; Qi, Longwu; Sahasrabudhe, Sudhir R.; Pierce, Michael; Robbins, Paul B.

Agent Shelston IP

Pub. Number AU-A-2006330883

PCT Pub. Number WO2007/076087

Priority 60/753,801 22.12.05 US; 60/833,855 27.07.06 US

Filing date 22 December 2006

Wipo publication date 5 July 2007

International Classifications

C07D 239/91 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

17 July 2008 PCT application entered the National Phase

  PCT publication WO2007/076087 Priority application(s): WO2007/076087

6 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006330888-Nitrogencontaining bicyclic hetroaryl compounds for the treatment of Raf protein kinase-mediated diseases

2006330880-Allergy inhibitor compositions and kits and methods of using the same